Paul D Bloom (CEO) sold ~$2.6K of Gevo
Planned saleWant the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
GEVO · NASDAQ · Industrial Organic Chemicals
$1.61−0.06 (−3.59%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Gevo (GEVO) · oqro.io/stocks/GEVO · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
42 routine filings (option exercises, shares withheld for taxes, grants, gifts) are not listed here. Show them
Paul D Bloom (CEO) sold ~$2.6K of Gevo
Planned salePatrick R. Gruber (Director) sold ~$5.7K of Gevo
Planned saleKimberly T Bowron (Chief of Staff) sold ~$2.1K of Gevo
Planned saleInsider buying
First insider buy since Mar 2022Traded Aug 21 · filed 3 days later
Since the trade +4.5% · S&P 500 −9.9% · to Nov 20
Bought 45% below the 52-week high, RSI 49, 18% under its 200-day average, 13 points behind the S&P 500 over 3 months
Insider buying
First insider buy since Mar 2022Traded Aug 21 · filed 3 days later
Since the trade +4.5% · S&P 500 −9.9% · to Nov 20
Bought 45% below the 52-week high, RSI 49, 18% under its 200-day average, 13 points behind the S&P 500 over 3 months
Patrick R. Gruber (Director) sold ~$374K of Gevo
Planned salePaul D Bloom (CEO) sold ~$48K of Gevo
Planned saleOluwagbemileke Yusuf Agiri (CFO) sold ~$28K of Gevo
Planned saleKimberly T Bowron (Chief of Staff) sold ~$16K of Gevo
Planned salePatrick R. Gruber (Director) sold ~$221K of Gevo
Planned saleOluwagbemileke Yusuf Agiri (CFO) sold ~$88K of Gevo
Planned salePaul D Bloom (CEO) sold ~$50K of Gevo
Planned saleChristopher Michael Ryan (President & COO) sold ~$50K of Gevo
Planned saleKimberly T Bowron (Chief of Staff) sold ~$22K of Gevo
Planned saleAndrew Shafer (Chief Mktg Cust & Brnd Officer) sold ~$13K of Gevo
Planned saleDavaajargal Gendenjamts (VP Acctg and Treasurer) sold ~$6.1K of Gevo
Planned salePaul D Bloom (CEO) sold ~$133K of Gevo
Planned salePatrick R. Gruber (Director) sold ~$328K of Gevo
Planned saleOluwagbemileke Yusuf Agiri (CFO) sold ~$57K of Gevo
Planned saleChristopher Michael Ryan (President & COO) sold ~$154K of Gevo
Planned saleAndrew Shafer (Chief Mktg Cust & Brnd Officer) sold ~$57K of Gevo
Planned saleKimberly T Bowron (Chief of Staff) sold ~$44K of Gevo
Planned saleAndrew Shafer (Chief Cust Mkt & Brnd Officer) sold ~$11K of Gevo
Planned saleAndrew Shafer (Chief Cust Mkt & Brnd Officer) sold ~$15K of Gevo
Planned saleChristopher Michael Ryan (President & COO) sold ~$276K of Gevo
Planned saleChristopher Michael Ryan (President & COO) sold ~$88K of Gevo
Planned saleInsider selling
Traded Mar 12 · filed the same dayNot reported under a pre-arranged trading plan
Since the trade −33.7% · S&P 500 +3.6% · to Nov 20
A Gevo director sold $250K of Gevo shares. The filing does not indicate a pre-arranged trading plan.
Lindsay Clinton Fitzgerald (Chief Public Affairs Officer) sold ~$50K of Gevo
Planned saleAndrew Shafer (Chief Cust Mkt & Brnd Officer) sold ~$12K of Gevo
Planned saleAndrew Shafer (Chief Cust Mkt & Brnd Officer) sold ~$9.9K of Gevo
Planned saleAndrew Shafer (Chief Cust Mkt & Brnd Officer) sold ~$11K of Gevo
Planned saleInsider selling
Traded Dec 5, 2025 · filed 3 days laterNot reported under a pre-arranged trading plan
Since the trade −29.7% · S&P 500 +0.6% · to Nov 20
The CFO of Gevo sold $169K of Gevo shares. The filing does not indicate a pre-arranged trading plan.
Davaajargal Gendenjamts (VP Acctg and Treasurer) sold ~$5.9K of Gevo
Automatic saleAndrew Shafer (Chief Cust Mkt & Brnd Officer) sold ~$9.9K of Gevo
Planned saleInsider selling
Traded Nov 13, 2025 · filed 1 day laterNot reported under a pre-arranged trading plan
Since the trade −19.5% · S&P 500 +2.6% · to Nov 20
A Gevo director sold $153K of Gevo shares. The filing does not indicate a pre-arranged trading plan.
Andrew Shafer (Chief Cust Mkt & Brnd Officer) sold ~$68K of Gevo
Planned saleAndrew Shafer (Chief Cust Mkt & Brnd Officer) sold ~$13K of Gevo
Planned saleAngelo Amorelli (Director) sold ~$250K of Gevo
Planned saleChristopher Michael Ryan (President & COO) sold ~$282K of Gevo
Planned saleAndrew Shafer (Chief Cust Mkt & Brnd Officer) sold ~$10K of Gevo
Planned sale2 open-market purchases and 27 open-market sales by insiders of GEVO between Feb 3, 2026 and today, placed against the company's last 4 earnings releases. The latest on file was filed Nov 10, 2026. The data provider lists the next release for Mar 3, 2027; that date may change.
PurchaseSale30 days before a release30 days after
| Earnings release | 30 days before | On the day | 30 days after |
|---|---|---|---|
| Nov 10, 2026 | None | None | None |
| Aug 6, 2026 | None | 4 sales | 2 purchases, 3 sales |
| May 7, 2026 | 1 sale | None | 6 sales |
| Mar 5, 2026 | None | None | 6 sales |
Companies set trading windows, which usually close shortly before results and reopen after them, and insiders may trade under 10b5-1 plans adopted months earlier. A date alone does not show what a person knew or why they traded. Past release dates are the dates the company filed its 8-K with Item 2.02. An upcoming date, when one is mentioned, comes from the data provider's earnings calendar (Finnhub): it is not a company filing, it is not estimated by OQRO, and it may change. Open-market purchases and sales as reported on Form 4. Largest purchases around earnings, all companies